Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 254

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance

Open access
Braza, Mounia S., van Leent, Mandy M.T., Lameijer, Marnix, Sanchez-Gaytan, Brenda L., Arts, Rob J.W., Pérez-Medina, Carlos, Conde, Patricia, Garcia, Mercedes R., Gonzalez-Perez, Maria, Brahmachary, Manisha, Fay, Francois, Kluza, Ewelina, Kossatz, Susanne, Dress, Regine J., Salem, Fadi, Rialdi, Alexander, Reiner, Thomas, Boros, Peter, Strijkers, Gustav J., Calcagno, Claudia C., Ginhoux, Florent, Marazzi, Ivan, Lutgens, Esther, Nicolaes, Gerry A.F., Weber, Christian, Swirski, Filip K., Nahrendorf, Matthias, Fisher, Edward A., Duivenvoorden, Raphaël, Fayad, Zahi A., Netea, Mihai G., Mulder, Willem J.M., Ochando, Jordi·2018·Immunity

Abstract

&NA; Inducing graft acceptance without chronic immunosuppression remains an elusive goal in organ transplantation. Using an experimental transplantation mouse model, we demonstrate that local macrophage activation through dectin‐1 and toll‐like receptor 4 (TLR4) drives trained immunity‐associated cytokine production during allograft rejection. We conducted nanoimmunotherapeutic studies and found that a short‐term mTOR‐specific high‐density lipoprotein (HDL) nanobiologic treatment (mTORi‐HDL) averted macrophage aerobic glycolysis and the epigenetic modifications underlying inflammatory cytokine production. The resulting regulatory macrophages prevented alloreactive CD8+ T cell‐mediated immunity and promoted tolerogenic CD4+ regulatory T (Treg) cell expansion. To enhance therapeutic efficacy, we complemented the mTORi‐HDL treatment with a CD40‐TRAF6‐specific nanobiologic (TRAF6i‐HDL) that inhibits co‐stimulation. This synergistic nanoimmunotherapy resulted in indefinite allograft survival. Together, we show that HDL‐based nanoimmunotherapy can be employed to control macrophage function in vivo. Our strategy, focused on preventing inflammatory innate immune responses, provides a framework for developing targeted therapies that promote immunological tolerance. Graphical Abstract Figure. No caption available. HighlightsVimentin and HMGB1 promote training of graft‐infiltrating macrophagesHDL‐nanobiologics target myeloid cells in hematopoietic organs and the allograftmTORi‐HDL prevents trained immunity and TRAF6i‐HDL inhibits CD40 costimulationNanoimmunotherapy with both mTORi‐ and TRAF6i‐HDL induces organ transplant acceptance &NA; An unresolved problem in organ transplantation is to establish graft acceptance in the absence of long‐term immunosuppressive therapy. Braza et al. unravel important molecular mechanisms underlying myeloid cell activation in an experimental organ transplantation model and develop a combined nanoimmunotherapy that targets myeloid cells in hematopoietic organs and the allograft. Short‐term nanobiologic immunotherapy prevents inflammation and induces indefinite allograft survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2018.09.008

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 254

Metadata

Authors
Braza, M. S., van Leent, M. M. T., Lameijer, M., Sanchez-Gaytan, B. L., Arts, R. J. W., Pérez-Medina, C., Conde, P., Garcia, M. R., Gonzalez-Perez, M., Brahmachary, M., Fay, F., Kluza, E., Kossatz, S., Dress, R. J., Salem, F., Rialdi, A., Reiner, T., Boros, P., Strijkers, G. J., Calcagno, C. C., Ginhoux, F., Marazzi, I., Lutgens, E., Nicolaes, G. A. F., Weber, C., Swirski, F. K., Nahrendorf, M., Fisher, E. A., Duivenvoorden, R., Fayad, Z. A., Netea, M. G., Mulder, W. J. M., & Ochando, J.
Venue
Immunity
Publisher
Elsevier BV
Published
2018-11
Volume
49
Issue
5
Pages
819-828.e6
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2899726004
Cited by
254
References
43
FWCI
8.28
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. https://app.cochat.ai/papers/10.1016/j.immuni.2018.09.008
The paper
Braza, M. S., van Leent, M. M. T., Lameijer, M., Sanchez-Gaytan, B. L., Arts, R. J. W., Pérez-Medina, C., Conde, P., Garcia, M. R., Gonzalez-Perez, M., Brahmachary, M., Fay, F., Kluza, E., Kossatz, S., Dress, R. J., Salem, F., Rialdi, A., Reiner, T., Boros, P., Strijkers, G. J., . . . Ochando, J. (2018). Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. Immunity. https://doi.org/10.1016/j.immuni.2018.09.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.